Introduction
Intracerebral haemorrhage can occur in cerebral hemispheres, basal ganglia, cerebellum and brain stem. Haemorrhage in the posterior cranial fossa has a particularly poor prognosis when compared with supratentorial haemorrhage; 1 cerebellar haemorrhage can compress the brainstem and/or the fourth ventricle and lead to hydrocephalus, midline shift or tonsillar herniation, whereas brainstem haemorrhage may cause cardiovascular and respiratory compromise. The principles of management of spontaneous intracerebral haemorrhage include: stopping or slowing the initial bleed (which may include reversal of anticoagulation or control of hypertension), possible surgical removal of clot, management of intracranial pressure (ICP), drainage of hydrocephalus, and supportive measures. 2 However, practice is often variable due to a lack of randomised controlled trials.
Observational studies show that about 30% of patients with supratentorial haemorrhage and almost all patients with brainstem or cerebellar haemorrhage have either decreased consciousness or bulbar muscle dysfunction necessitating intubation. 3 Tracheostomy plays an integral role in the airway management of such patients and proposed benefits over prolonged endotracheal intubation include: lower airway resistance, more effective suctioning, greater patient comfort, better communication, oral feeding, faster weaning from the ventilator, and lower rates of ventilator-associated pneumonia. 4 However, tracheostomy can be complicated by dislodgement or obstruction, wound infection, scarring, creation of a false passage, haemorrhage and subglottic and tracheal stenosis. 5 It has been shown previously that tracheostomy has no significant effect on intensive care unit (ICU) length of stay and predicted mortality in the context of head trauma. 6 More recent studies found that early tracheostomy resulted in shorter ICU stay thereby reducing the total cost and complications such as nosocomial infections in these patients. 7, 8 Currently, the randomised pilot trial SETPOINT in patients with ischaemic stroke, intracerebral haemorrhage and subarachnoid haemorrhage aims to investigate the safety, feasibility, and potential benefit of early tracheostomy vs prolonged intubation. 9 However, a lack of data regarding the impact of tracheostomy compared to prolonged endotracheal intubation on patient outcomes in the context of posterior fossa bleeds continues to exist. The timing of tracheostomy also remains subject to practice variation. Some studies show that the timing of tracheostomy does not alter the duration of mechanical ventilation, 10 whereas others argue that early tracheostomy reduces the time spent on a ventilator but with no effect on mortality. 11 Currently, the recommendations for timing of tracheostomy have been based on expert consensus. 12, 13 This proposes an anticipatory approach where tracheostomy is considered after an initial period of endotracheal mechanical ventilation when it becomes apparent that the patient will require prolonged ventilatory assistance.
The aim of this study was to assess current tracheostomy practice for patients with posterior fossa bleeds admitted to the Addenbrooke' s NCCU, analyse the impact of the timing of tracheostomy on length of stay, and identify factors that may predict prolonged ventilation and thereby patients that may benefit from early tracheostomy.
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Studies indicate that early tracheostomy may improve outcomes in critically ill patients, but there is a lack of data specifically relating to patients with posterior fossa haemorrhage. This retrospective study assesses the type and duration of airway management for patients with posterior fossa haemorrhage admitted to a neurocritical care unit (NCCU). Of the 21 patients identified, seven required no airway intervention, eight were managed with endotracheal intubation alone, and six required tracheostomy. Although the median length of airway management for patients with endotracheal intubation alone was two days (n=8), the median delay to tracheostomy was 11 days (n=6). Four patients requiring intubation did not survive their NCCU stay. No patient was successfully extubated later than two days post admission. We recommend early tracheostomy in patients who are not extubatable within a few days of admission but in whom admission characteristics and neurological progress otherwise suggest survival with useful recovery.
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Methods
Patients with radiologically confirmed posterior fossa bleeds admitted to Addenbrooke' s NCCU over two years (2007) (2008) (2009) were retrospectively identified and their medical notes reviewed for GCS on admission, location of haemorrhage (brainstem, cerebellum or both), suspected causation, the type and duration of airway management (tracheostomy, endotracheal tube (ETT), none), delay to tracheostomy, any intervention (surgical evacuation, extra-ventricular drain (EVD), none), length of NCCU and hospital stay, and unit outcome. The delay to tracheostomy was taken to be the duration from initiation of mechanical ventilation to tracheostomy.
GraphPad Prism (GraphPad Software, Inc; La Jolla, CA, USA) was used for statistical analysis and graphing. Data were expressed as the medians ± interquartile range and compared using the Mann-Whitney U test. Associations between parametric data were tested using regression and nonparametric data using Spearman-Rank Correlation. Statistical significance was accepted when p<0.05.
Results
Demographic data and main outcomes are given in Table 1 . Of the 21 NCCU patients with posterior fossa bleeds, seven (33%) required no airway intervention, eight (38%) were managed with endotracheal intubation alone, and six (29%) required tracheostomy. The median length of airway management for those patients with ETT alone was two days (range 1-7 days, n=8). The median time to successful extubation for those patients with ETT airway management alone was two days. Four of the patients who required active airway management with endotracheal intubation did not survive their NCCU stay; one patient satisfied brainstem death criteria, while active treatment was withdrawn in the remaining three in the context of a bleak neurological prognosis. Those extubated after two days of endotracheal ventilation in NCCU were all terminal extubations (Figure 1) .
The median delay to tracheostomy was found to be 11 days (range 7-26 days, n=6). For those patients who underwent tracheostomy, there was a positive correlation between delay to tracheostomy and NCCU length of stay (r 2 = 0.73; p = 0.03; n=6).
Hypertension was the only suspected causative factor of posterior fossa bleeds in 11 patients and had no effect on NCCU length of stay when compared to other causes (Mann-Whitney U; p=0.16). The majority of bleeds were located in the cerebellum (n=16), four in the brainstem alone and one in both. The location of the bleed did not affect NCCU length of stay (Mann-Whitney U; p=0.59). The median GCS score on admission to NCCU of patients who underwent a tracheostomy (4, n=6) was lower than for those patients whose airways were managed with ETT alone (7, n=8) but this was not found to be statistically significant (Mann-Whitney U; p=0.29). There was a negative correlation between GCS on admission and length of stay on NCCU (Spearman ρ=-0.42), but this also failed to reach significance (p=0.06).
Discussion
In 1989, the American College of Chest Physicians Consensus Statement on Artificial Airways in Patients Receiving
Mechanical Ventilation considered endotracheal intubation to be the preferred technique for patients requiring up to 10 days of mechanical ventilation and recommended tracheostomy for those with anticipated need for artificial airway for more than 21 days. 12 The absence of clear criteria for selecting patients for tracheostomy results in considerable variation in the timing of the procedure for ventilator-dependent patients with local practice preferences, rather than patient factors, guiding care. 13 In our experience, it is clinically difficult to predict who will need prolonged ventilation and therefore who would benefit from a tracheostomy, which may explain the variability in timing of tracheostomy (7-26 days post intubation) for patients Figure 1 The summary of airway management in patients admitted to NCCU with posterior fossa bleeds; demonstrating a delay of five days between the last successful extubation (purple) to the first tracheostomy (blue). Four patients were terminally extubated after two days of endotracheal ventilation (red).
with posterior fossa bleeds in our study.
Some respiratory parameters such as alveolar-arterial oxygen gradient, positive end-expiratory pressure and PaO 2 /FiO 2 ratio have been used as predictors of prolonged intubation in trauma and burns patients, [14] [15] [16] [17] [18] but unfortunately such predictive methods are not available for patients with intracranial haemorrhage. The greatest causative factor, hypertension, and the most common location of the bleed, cerebellum, were not found to affect NCCU length of stay. GCS on admission has been shown to act as a predictor for long-term mechanical ventilator support in trauma patients. 19, 20 Our results demonstrate that a low GCS on admission is associated with a prolonged length of NCCU stay. Although not significant in our small cohort of patients, further studies are needed to investigate the possible use of GCS on admission to identify patients with posterior fossa haemorrhage who may benefit from early tracheostomy.
The data show that although the median length of airway management for those patients with ETT alone was two days, the median delay to tracheostomy was found to be 11 days. Although successful extubation with survival was not observed after the second day post NCCU admission, patients did not receive tracheostomy until seven days at the earliest, with one patient waiting for 16 days. The data suggest that patients who have been intubated for longer than two days are unlikely to be successfully extubated in the near future and could potentially have an early tracheostomy. This would reduce the variability in practice that currently exists in our unit. However, careful patient selection is required to exclude those who are unlikely to survive and therefore benefit from a tracheostomy.
A randomised controlled trial on tracheostomy timing found that early tracheostomy actually improves mortality and reduces the incidence of pneumonia compared with late tracheostomy in critically ill patients. 17 A recent Cochrane review of early (≤10 days after intubation) versus late (>10 days after intubation) tracheostomy in critically ill patients showed no strong evidence for real differences in the primary outcome of mortality and highlighted a lack of specific subgroups of patients. 21 The UK TracMan trial, recently completed and awaiting publication, addressed the effectiveness and safety of early versus late tracheostomy in critically ill adult patients, 22 but found no differences between the two groups (http://www.intensive.org/newsletter/ fullday3.html). Although the SETPOINT trial aims to investigate the effect of early tracheostomy (≤3 days from intubation) in patients with ischaemic and haemorrhagic strokes, 9 none of the existing or emerging evidence is specifically targeted at patients with posterior fossa haemorrhage in the neuro-intensive care setting.
Spontaneous posterior fossa haemorrhage often requires surgical decompression or drain device insertion. This was true for 57% of our patients (12/21). There are reports in the literature that following these interventions to evacuate clot, patients showed a significant improvement in GCS and that 58.6% of the 62% of patients who survived were functionally independent according to the Rankin scale. This suggests that if early tracheostomy is found to reduce mortality in this subgroup of patients, a large proportion should be expected to have good functional outcomes.
We found that delay to tracheostomy was associated with increased NCCU length of stay, but given the number of potential confounders, it was not possible to calculate whether delayed tracheostomy is an independent predictor of prolonged NCCU stay since the dataset was not large enough to perform multivariate analyses. However, other studies have suggested this may be the case. 18 A retrospective study by Koh et al found that elective tracheostomy for selected patients with low GCS scores and nosocomial pneumonia has resulted in shortened ICU length of stay and rapid weaning from ventilatory support. 24 This indicates that early tracheostomy may also play a role in improving the outcome in patients with posterior fossa haemorrhage but more research is needed to evaluate this further.
Conclusions
Patients with posterior fossa haemorrhage who require intubation and ventilation for longer than two days and in whom admission characteristics and neurological progress otherwise suggest survival with useful recovery, could undergo early tracheostomy (>2 days of intubation) since the data suggest they are unlikely to be successfully extubated in the near future. To clarify the potential benefits of early tracheostomy in this cohort of patients a randomised multicentre trial is needed.
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